“Best Hospitals” cancer-care rank: 30
“Best Hospitals” cancer-care score: 58.8/100
Cancer biology, cancer epigenetics, developmental therapeutics, immune-cell development and host defense, and cancer prevention and control.
At Fox Chase Cancer Center, new technologies and cancer treatments often are available before becoming standard practice in the broader cancer-care community. For example, it offers CancerCode, a DNA sequencing test allowing tumor-specific genetic alterations to be precisely matched with a choice of chemotherapy drugs likely to work best for the individual patient. Fox Chase enjoys an enviable reputation for research — two of its scientists won Nobel Prizes, one for history’s first cancer vaccine. It operates state-of-the-art lab facilities in support of biotechnology, clinical, cell biology, computing/information, and genetic research. At any one time, about 170 clinical trials of new prevention, diagnostic and treatment techniques are under way. The center has a special clinical-studies wing that includes a 10-bed special-care unit for patients participating in Phase I clinical trials. Now part of Temple University Health System, one of Philadelphia’s leading academic health centers, Fox Chase is a National Cancer Institute-designated comprehensive cancer center.